Datta Sibnarayan, Agarwal Manisha, Chatterjee Soumya, Gogoi Hemanta Kumar, Veer Vijay, Singh Lokendra
Scientist 'C', Biodefence & Biotechnology Division, Defence Research Laboratory Tezpur (DRDO), Tezpur 784 001, Assam, India.
Graded Specialist (Pathology), Military Hospital Allahabad, C/o 56 APO, India.
Med J Armed Forces India. 2015 Apr;71(2):182-5. doi: 10.1016/j.mjafi.2013.04.014. Epub 2013 Aug 5.
Human papillomavirus (HPV) associated cervical cancer is the leading cause of deaths in India. However, cytological/HPV screening may result in early detection of cervical cancer, resulting in early treatment and reduced mortality. Although reports related to general population is available, data on HPV prevalence among women attending AFMS health care facilities is scarce. Cervical samples were collected for cytological staining by Pap test and molecular detection by PCR, genotyping by HPV specific primers and sequencing. Apart from finding of atypical cells of undetermined significance (ASCUS) in one subject, no evidence of malignancy was observed. A high prevalence of HPV was found in this study group, which was intermediate between previous reports from general population and cervical cancer patients. All the subjects had infection of high risk HPV type16. HPV prevalence was found similar between different age groups. Although, none of the study subjects had malignant changes, but due to high prevalence of high risk HPV infection and other associated risk factors, these subjects might be at an elevated risk of developing cervical cancer. Regular follow-up of these patients who were detected HPV positive are required to screen for cervical malignancy.
人乳头瘤病毒(HPV)相关的宫颈癌是印度女性死亡的主要原因。然而,细胞学/HPV筛查可能有助于早期发现宫颈癌,从而实现早期治疗并降低死亡率。尽管有关于普通人群的报告,但在空军医疗服务(AFMS)医疗机构就诊的女性中,HPV流行率的数据却很匮乏。收集宫颈样本进行巴氏试验的细胞学染色、通过聚合酶链反应(PCR)进行分子检测、使用HPV特异性引物进行基因分型以及测序。除了在一名受试者中发现意义不明确的非典型细胞(ASCUS)外,未观察到恶性肿瘤的证据。在该研究组中发现HPV的高流行率,这一流行率介于先前普通人群和宫颈癌患者报告之间。所有受试者均感染了高危HPV 16型。不同年龄组之间的HPV流行率相似。虽然该研究的所有受试者均未发生恶性病变,但由于高危HPV感染的高流行率以及其他相关风险因素,这些受试者患宫颈癌的风险可能会升高。需要对这些检测出HPV阳性的患者进行定期随访,以筛查宫颈恶性肿瘤。